ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concept For studies Of Thorotrast Exposure

November 16, 1990

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

In Brief: Adamson Takes Job at Soft Drink Association; Zack Hall to Direct Neurological Institute

August 12, 1994

President Clinton Seeks 8% Increase For NCI; Most Institute Take Cuts In $10 Bll. NIH Budget

April 16, 1993

In Brief: David Cole Named President of The Medical University of South Carolina

May 9, 2014

Proton Beam Radiation Helps Cancer Patients Retain Vision

August 26, 2005